FDA approves Alzheimer’s drug donanemab after months of delay

Science

Fda Approves Alzheimer’s Drug Donanemab After Months Of Delay

By The Washington Post

The Food and Drug Administration granted approval Tuesday to a closely watched Alzheimer’s drug, concluding that the benefits of modestly slowing the progression of the devastating disease outweigh its risks, drugmaker Eli Lilly announced. The agency ...Read more

Related Posts

Study finds distinct brain networks linked to sex and gender

Study finds distinct brain networks linked to sex and gender

Jul 12, 2024
Signs of Alzheimer’s were everywhere. Then his brain improved

Signs of Alzheimer’s were everywhere. Then his brain improved

May 18, 2024
Nikon’s Small World in Motion Captures Microscopic Life at Its Trippiest

Nikon’s Small World in Motion Captures Microscopic Life at Its Trippiest

Sep 17, 2024
'Western diet' may raise risk of early-onset colorectal cancer

'Western diet' may raise risk of early-onset colorectal cancer

Jun 04, 2024
We use cookies to help provide you with the best experience when you visit our websites. By using this site you consent to the use of cookies on your device. see our cookie policy.